BAST supports early stage drug development programs by providing translational PKPD models, which predict the pharmacological response in humans based on preclinical data. In the past we have scaled PK parameters between species in order to select safe starting doses for first in man clinical trials and predict efficacious dose ranges based on preclinical information. Moreover, we have scaled adult PK/PD models to paediatric patients to support the writing of paediatric investigation plans (PIP) and proposed paediatric study requests (PPSR).
Contact us for more information or a quote, if you think that our services will be of help to you!
